Concept:
A middle-aged female patient presents with the insidious onset of severe fatigue and relentless pruritus, accompanied biochemically by a disproportionately elevated alkaline phosphatase (a cholestatic pattern). A normal abdominal ultrasound reliably rules out any extrahepatic mechanical biliary obstruction.
This clinical and demographic presentation is the absolute textbook description of Primary Biliary Cholangitis (historically and formerly known as Primary Biliary Cirrhosis).
*(Note: The question explicitly asks "Which of the following antibodies...", yet the provided options bizarrely list disease names instead of specific antibodies. ).*
Explanation:
• Primary Biliary Cholangitis (PBC) is a chronic, slowly progressive autoimmune disease of the liver that predominantly affects middle-aged women (female-to-male ratio is roughly 9:1).
• The disease is characterized by a T-cell-mediated autoimmune destruction of the small, intralobular bile ducts within the liver, eventually leading to profound cholestasis, progressive fibrosis, and ultimately end-stage cirrhosis.
• Clinically, patients classically present with severe, debilitating fatigue and intense pruritus, often preceding the onset of clinical jaundice by several years.
• Biochemical profiling universally reveals a cholestatic picture, with prominently elevated Alkaline Phosphatase (ALP) and Gamma-Glutamyl Transferase (GGT), alongside relatively mild elevations in AST and ALT.
• The absolute hallmark, highly specific diagnostic autoantibody for PBC is the Antimitochondrial Antibody (AMA), which is found to be positive in over 95% of afflicted patients.
• Although the question prompt specifically asked for an "antibody", the options incorrectly provide disease names. Based on the classic female demographic and the pure cholestatic presentation without extrahepatic ductal involvement, the intended correct answer is the disease itself: Primary Biliary Cirrhosis (Option A).
• Primary sclerosing cholangitis (Option B) typically affects younger males with concurrent IBD.
• HCV infection (Option C) and Autoimmune hepatitis (Option D) primarily cause a hepatocellular injury pattern (markedly elevated transaminases) rather than isolated cholestasis.
Final Answer:
Despite the typographical error in the options, the clinical presentation is classic for Primary Biliary Cirrhosis (which is associated with the AMA antibody).